The lawsuit filed in October alleged that Medica refused to provide full reimbursement for tests conducted by the Nebraska-based lab company. GS Labs argued that the federal CARES Act required the insurer to pay the full price of tests as listed on the company’s website, according to the report.
U.S. District Court Judge Susan Richard Nelson ruled that the law does not give testing companies the right to seek payments from insurers through lawsuits, according to the report.
“While diagnostic testing providers may have incidentally benefited from the goal of providing COVID-19 testing access to patients, the CARES Act was not intended to especially benefit testing providers,” Ms. Nelson wrote in her order, according to the report.
GS Labs is reviewing its legal options, a company spokesperson told the news outlet.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
